On April 23, we suggested investors take a bullish posture on NVO, the maker of Ozempic (a popular diabetes therapy) and Wegovy (the popular weight loss drug). This article is for paid members - please login or subscribe for access. Username Password Remember Me Forgot Password Share: Mark W. Guthner, CFA Previous Post Apple Inc: AAPLNext PostDollar General: DG You Might Also Like Block: SQ March 11, 2023 Inflation Nation: BHP Group Limited March 15, 2022 There’s Something Skewy Going On in IBIT March 27, 2025
You Might Also Like Block: SQ March 11, 2023 Inflation Nation: BHP Group Limited March 15, 2022 There’s Something Skewy Going On in IBIT March 27, 2025
